An August study published in the Journal of Infectious Diseases reveals that a school-based human papillomavirus (HPV) immunization program was credited with a 57.9% reduction of cervical precancer rates among women living in British Columbia (BC), Canada.
Senior research advisor Gina Ogilvie, MD, BC Women’s Hospital and Health Center and professor at the UBC School of Population and Public Health, emphasized the stark impact of vaccination adherence to decreased precancer rates. “This study contributes to the growing body of evidence highlighting the positive impact of the HPV vaccine and regular cervical screening on preventing cervical cancer. And, with increased vaccine uptake, we would expect to see a further decrease in cervical cancer rates,” said Ogilvie.
